Characterization of Cancer Trials
Patient population – life-threatening and irreversible
Treatments – cytotoxic agents:
No efficacy at lower doses but with severe immunosuppression, hepatic, renal, and cardiac toxicity
Efficacious at high doses but with possible fatal or life-threatening AEs
